Samsung Biologics unveils $920 million manufacturing deals for Pfizer
SEOUL (Reuters) – South Korea’s Samsung Biologics announced on Tuesday
biologics
U.S. Commerce removes Wuxi Biologics from unverified list
(Reuters) – The Biden administration said Thursday it had removed
China’s Innovent Biologics secures over $300 million investment from Sanofi
(Reuters) – Innovent Biologics Inc said on Friday Paris-based Sanofi
WuXi Biologics sees no impact from addition to unverified list for U.S. exports
BEIJING – WuXi Biologics said in a statement on Tuesday